Briefing: FDA slams Soon-Shiong and ImmunityBio for making ‘false and misleading’ claims about a drug

Strategic angle: Patrick Soon-Shiong, a controversial figure in the biotech industry, was accused by the FDA of making false and misleading claims about a cancer treatment.